Stock listing

Crescent Biopharma, Inc.

Selected listing: A41BDZ · LS · EUR · DE

Crescent Biopharma, Inc. (Lang & Schwarz: A41BDZ), Health Technology. Latest release Oct 6, 2026: Crescent Biopharma Announces Grants of Inducement Awards.

A41BDZ:LSEURDEUpdated October 3, 2026
Crescent Biopharma, Inc. logo
Ticker
Lang & Schwarz: A41BDZ
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
Lang & Schwarz
Currency
EUR

About Crescent Biopharma, Inc.

The company focuses on biopharmaceutical development and innovation. As part of the American market, Crescent Biopharma aims to advance healthcare through its research and product offerings.

Latest news from Crescent Biopharma, Inc.

All Crescent Biopharma, Inc. news →

Events

Replays

  • GlycoMimetics, Inc. (GLYC) Q1 2024 Earnings Call

    Thu, May 09, 2024 · 08:30 AM ET

    Watch
  • GlycoMimetics, Inc. (GLYC) Q4 2023 Earnings Call

    Wed, Mar 27, 2024 · 08:30 AM ET

    Watch
  • GlycoMimetics, Inc. (GLYC) Q3 2023 Earnings Call

    Fri, Nov 03, 2023 · 08:30 AM ET

    Watch

Research Crescent Biopharma, Inc.

Alternate listings